For Researchers
ArtFun+ provides clinically-validated imaging biomarkers that help clinical researchers publish more & in higher impact-factor journals.
Empower your research studies with precision biomarkers
ArtFun + provides arterial stiffness and flow biomarkers that help researchers make the most of their MRI data in growing therapeutic areas to enhance the understanding of CV diseases: ArtFun+ biomarkers are commonly recognized as a major risk factor for CV diseases and considered as major predictors of cardiovascular mortality.
Start Boosting your productivity for scientific publications and take your research to the next level .
Publish with confidence
ArtFun+ technology was endorsed by more than 77 publications in 13 countries and empowered the understanding of CV diseases – indicating a trusted method by world-class journals.
Publish Faster
Access individual data in 2 min vs 20 mn.
Analyze entire data base using our outsourcing service.
Influence clinical Practice
Demontrated ability to use novel precision biomarkers ( independent of traditional risk factors and CAC) to detect early CVD risks ( e.g. for young, obese, asymptomatic patients).
Let’s Drive Adoption
With More Scientific Evidence